13F-HR filed by Prosight Management, LP
Prosight Management, LP filed this 13F-HR for the quarter ended 2025-06-30, filed 2025-08-14, with 39 holding rows worth $410,062,650.
- Accession
- 0001420506-25-002021
- Filer
- CIK 1617201
- Filed
- 2025-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2025
A holdings report, 39 entries on the cover page, a total value of $410,062,650 stated on the cover page (in dollars after the unit check, H1), rows summing to $410,062,650 with VALUE read as dollars as filed, 13F file number 028-18450. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| LAKEFRONT BIOTHERAPEUTICS NV | 36315X101 | SPON ADR | 1,773,649 | $49,644,436 | dollars as filed | |
| UnitedHealth Group Inc | 91324P102 | COM | 110,000 | $34,316,700 | dollars as filed | |
| MEIRAGTX HOLDINGS PLC | G59665102 | COMMON STOCK | 4,587,423 | $29,909,998 | dollars as filed | |
| ADC THERAPEUTICS SA | H0036K147 | COMMON STOCK | 10,467,771 | $28,053,626 | dollars as filed | |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 472,687 | $20,410,625 | dollars as filed | |
| ROIVANT SCIENCES LTD | G76279101 | SHS | 1,808,539 | $20,382,235 | dollars as filed | |
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 3,480,044 | $19,940,652 | dollars as filed | |
| JANUX THERAPEUTICS INC | 47103J105 | COM | 853,904 | $19,725,182 | dollars as filed | |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 3,181,184 | $18,355,432 | dollars as filed | |
| ZYMEWORKS INC | 98985Y108 | COM | 1,309,904 | $16,439,295 | dollars as filed | |
| ICON PUB LTD CO SHS | G4705A100 | Stock | 98,558 | $14,335,261 | dollars as filed | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 22,000 | $12,126,840 | dollars as filed | |
| MIRUM PHARMACEUTICALS INC | 604749101 | COM | 200,000 | $10,178,000 | dollars as filed | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 1,079,673 | $10,111,138 | dollars as filed | |
| TECTONIC THERAPEUTIC INC | 878972108 | COMMON STOCK | 442,056 | $8,783,653 | dollars as filed | |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 298,123 | $8,574,017 | dollars as filed | |
| CYTOMX THERAPEUTICS INC | 23284F105 | COMMON STOCK | 3,517,113 | $7,983,847 | dollars as filed | |
| IMMUNOVANT INC | 45258J102 | COM | 479,400 | $7,670,400 | dollars as filed | |
| BIOHAVEN LTD | G1110E107 | COM | 539,071 | $7,606,292 | dollars as filed | |
| CONCENTRA GROUP HOLDINGS PAR | 20603L102 | COMMON STOCK | 312,105 | $6,420,000 | dollars as filed | |
| LIVANOVA PLC | G5509L101 | SHS | 140,000 | $6,302,800 | dollars as filed | |
| DEXCOM INC COM | 252131107 | Stock | 70,000 | $6,110,300 | dollars as filed | |
| CAREDX INC | 14167L103 | COM | 302,808 | $5,916,868 | dollars as filed | |
| SELECT MED HLDGS CORP | 81619Q105 | COM | 353,820 | $5,370,988 | dollars as filed | |
| SHATTUCK LABS INC | 82024L103 | COMMON STOCK | 6,638,935 | $5,256,709 | dollars as filed | |
| ACADIA HEALTHCARE COMPANY INC COM | 00404A109 | Stock | 211,816 | $4,806,105 | dollars as filed | |
| CORBUS PHARMACEUTICALS | 21833P301 | COM NEW | 579,893 | $4,001,262 | dollars as filed | |
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 1,580,588 | $3,872,441 | dollars as filed | |
| SIGHT SCIENCES INC | 82657M105 | COMMON STOCK | 871,687 | $3,600,067 | dollars as filed | |
| AXOGEN INC | 05463X106 | COM | 282,809 | $3,068,478 | dollars as filed | |
| LANTHEUS HLDGS INC | 516544103 | COM | 34,576 | $2,830,391 | dollars as filed | |
| MURAL ONCOLOGY PUB LTD CO | G63365103 | ORD SHS | 900,000 | $2,223,000 | dollars as filed | |
| PROTHENA CORP PLC SHS | G72800108 | Stock | 267,800 | $1,625,546 | dollars as filed | |
| ORTHOPEDIATRICS CORP | 68752L100 | COMMON STOCK | 73,647 | $1,581,938 | dollars as filed | |
| PLIANT THERAPEUTICS INC | 729139105 | COM | 837,400 | $971,384 | dollars as filed | |
| REIN THERAPEUTICS INC | 00887A204 | COM NEW | 427,919 | $599,087 | dollars as filed | |
| ONKURE THERAPEUTICS INC | 68277Q105 | COM CL A | 159,692 | $381,664 | dollars as filed | |
| ERASCA INC COM | 29479A108 | Stock | 240,295 | $305,175 | dollars as filed | |
| PEPGEN INC COM | 713317105 | Stock | 243,980 | $270,818 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001420506-25-002021 | this filing | 2025-08-14 | acceptance time not in the bulk data set |